Incannex Healthcare Ltd receives ethics approval to start phase 1 clinical trial for CBD anti-inflammatory drug
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has obtained ethics approval from the Bellberry Human Analysis Ethics Committee (HREC) to start ...